The DOI matches its Crossref record; 249 of the 249 references it cites were found in a registry or an index.
Histone deacetylase inhibitor (HDACI) mechanisms of action: Emerging insights
Open accessAbstract
Initially regarded as “epigenetic modifiers” acting predominantly through chromatin remodeling via histone acetylation, HDACIs, alternatively referred to as lysine deacetylase or simply deacetylase inhibitors, have since been recognized to exert multiple cytotoxic actions in cancer cells, often through acetylation of non-histone proteins. Some well-recognized mechanisms of HDACI lethality include, in addition to relaxation of DNA and de-repression of gene transcription, interference with chaperone protein function, free radical generation, induction of DNA damage, up-regulation of endogenous inhibitors of cell cycle progression, e.g., p21, and promotion of apoptosis. Intriguingly, this class of agents is relatively selective for transformed cells, at least in pre-clinical studies. In recent years, additional mechanisms of action of these agents have been uncovered. For example, HDACIs interfere with multiple DNA repair processes, as well as disrupt cell cycle checkpoints, critical to the maintenance of genomic integrity in the face of diverse genotoxic insults. Despite their pre-clinical potential, the clinical use of HDACIs remains restricted to certain subsets of T-cell lymphoma. Currently, it appears likely that the ultimate role of these agents will lie in rational combinations, only a few of which have been pursued in the clinic to date. This review focuses on relatively recently identified mechanisms of action of HDACIs, with particular emphasis on those that relate to the DNA damage response (DDR), and discuss synergistic strategies combining HDACIs with several novel targeted agents that disrupt the DDR or antagonize anti-apoptotic proteins that could have implications for the future use of HDACIs in patients with cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
6 retracted
RETRACTED: Human SIRT6 Promotes DNA End Resection Through CtIP Deacetylation
Kaidi, A., Weinert, B. T., Choudhary, C., & Jackson, S. P. (2010) · Science · doi:10.1126/science.1192049 · Cited by 366
RetractedChen, C.-S., Wang, Y.-C., Yang, H.-C., Huang, P.-H., Kulp, S. K., Yang, C.-C., Lu, Y.-S., Matsuyama, S., Chen, C.-Y., & Chen, C.-S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3996 · Cited by 187
RetractedDasmahapatra, G. P., Lembersky, D., Kramer, L. B., Fisher, R. I., Friedberg, J. W., Dent, P., & Grant, S. (2010) · Blood · doi:10.1182/blood-2009-12-257261 · Cited by 115
Self-citationRetractedRosato, R. R., Maggio, S. C., Almenara, J. A., Payne, S. G., Atadja, P. W., Spiegel, S., Dent, P., & Grant, S. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.017145 · Cited by 91
Self-citationRetractedRosato, R. R., Kolla, S. S., Hock, S. K., Almenara, J. A., Patel, A. K., Amin, S., Atadja, P. W., Fisher, P. B., Dent, P., & Grant, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.095208 · Cited by 65
Self-citationRetractedDasmahapatra, G. P., Lembersky, D., Son, M. P., Attkisson, E., Dent, P., Fisher, R. I., Friedberg, J. W., & Grant, S. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-1108 · Cited by 62
Self-citationRetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Lysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040 · cited 2×
“P A A uthor M anuscript flap structure-specific endonuclease 1 (FEN1), Werner syndrome (WRN), ATM, mediator of DNA damage checkpoint 1 (MDC1) and DNA PK) is through acetylation (Choudhary et al., 2009).”
BackgroundNuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519 · cited 1×
“The NF-κB pathway mediates a cytoprotective response strongly implicated in cancer development and progression (reviewed in (Karin, 2006)) that is activated by HDACIs and limits their lethality (Dai et al., 2005; Dai, Chen, Wang, Pei, Funk et al., 2011; Rosato et al., 2010).”
BackgroundDNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Souers, A. J., Leverson, J. D., Boghaert, E. R., Ackler, S. L., Catron, N. D., Chen, J., Dayton, B. D., Ding, H., Enschede, S. H., Fairbrother, W. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3048 · Cited by 3,058
Anticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919 · cited 3×
“Some of these (the hydroxamic acids) act as pan-HDACIs, whereas others predominantly target the class I (entinostat, mocetinostat) or class IIb (e.g., ACY-1215) enzymes (Bolden et al., 2006; Grant & Dai, 2012).”
BackgroundCell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
DNA double-strand breaks: signaling, repair and the cancer connection
Khanna, K. K., & Jackson, S. P. (2001) · Nature Genetics · doi:10.1038/85798 · Cited by 2,455
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1779 · Cited by 2,200
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
Tse, C., Shoemaker, A. R., Adickes, J., Anderson, M. G., Chen, J., Jin, S., Johnson, E. F., Marsh, K. C., Mitten, M. J., Nimmer, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5836 · Cited by 1,992
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Soucy, T. A., Smith, P. G., Milhollen, M. A., Berger, A. J., Gavin, J. M., Adhikari, S., Brownell, J. E., Burke, K. E., Cardin, D. P., Critchley, S., et al. (2009) · Nature · doi:10.1038/nature07884 · Cited by 1,990
Kawaguchi, Y., Kovacs, J. J., McLaurin, A., Vance, J. M., Ito, A., & Yao, T.-P. (2003) · Cell · doi:10.1016/s0092-8674(03)00939-5 · Cited by 1,524
Human CtIP promotes DNA end resection
Sartori, A. A., Lukas, C., Coates, J., Mistrik, M., Fu, S., Bartek, J., Baer, R., Lukas, J., & Jackson, S. P. (2007) · Nature · doi:10.1038/nature06337 · Cited by 1,362 · cited 2×
“Critical steps in HR include CtBP interacting protein (CtIP)-mediated resection of the DSB in a 5′-3′ fashion (Huertas & Jackson, 2009; Sartori et al., 2007), followed by the recruitment and assembly of RAD51 into a nucleoprotein filament, which involves RAD52, x-ray repair cross-complementing proteins (XRCC) 2 and 3…”
MethodConserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage
Falck, J., Coates, J., & Jackson, S. P. (2005) · Nature · doi:10.1038/nature03442 · Cited by 1,258
The DNA-dependent protein kinase: Requirement for DNA ends and association with Ku antigen
Gottlieb, T. M., & Jackson, S. P. (1993) · Cell · doi:10.1016/0092-8674(93)90057-w · Cited by 1,243
van Delft, M. F., Wei, A. H., Mason, K. D., Vandenberg, C. J., Chen, L., Czabotar, P. E., Willis, S. N., Scott, C. L., Day, C. L., Cory, S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.027 · Cited by 1,240
Willis, S. N., Chen, L., Dewson, G., Wei, A., Naik, E., Fletcher, J. I., Adams, J. M., & Huang, D. C. S. (2005) · Genes & Development · doi:10.1101/gad.1304105 · Cited by 1,233
Regulation of DNA repair throughout the cell cycle
Branzei, D., & Foiani, M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2351 · Cited by 1,228
Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation
Chen, L.-F., Fischle, W., Verdin, E., & Greene, W. C. (2001) · Science · doi:10.1126/science.1062374 · Cited by 1,222
Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair
Walker, J. R., Corpina, R. A., & Goldberg, J. (2001) · Nature · doi:10.1038/35088000 · Cited by 1,212
Richon, V. M., Sandhoff, T. W., Rifkind, R. A., & Marks, P. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180316197 · Cited by 1,090
Konopleva, M., Contractor, R., Tsao, T., Samudio, I., Ruvolo, P. P., Kitada, S., Deng, X., Zhai, D., Shi, Y.-X., Sneed, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.006 · Cited by 1,023
Cell cycle kinases as therapeutic targets for cancer
Lapenna, S., & Giordano, A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2907 · Cited by 905
Roberts, A. W., Seymour, J. F., Brown, J. R., Wierda, W. G., Kipps, T. J., Khaw, S. L., Carney, D. A., He, S. Z., Huang, D. C. S., Xiong, H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.7898 · Cited by 830
Deacetylation of p53 modulates its effect on cell growth and apoptosis
Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000) · Nature · doi:10.1038/35042612 · Cited by 818
Bali, P., Pranpat, M., Bradner, J., Balasis, M., Fiskus, W., Guo, F., Rocha, K., Kumaraswamy, S., Boyapalle, S., Atadja, P., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500186200 · Cited by 755
Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
Pan, R., Hogdal, L. J., Benito, J. M., Bucci, D., Han, L., Borthakur, G., Cortes, J., DeAngelo, D. J., Debose, L., Mu, H., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0609 · Cited by 735
Histone deacetylase inhibitors: Potential in cancer therapy
Marks, P. A., & Xu, W. ‐. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22185 · Cited by 712
Juergens, R. A., Wrangle, J., Vendetti, F. P., Murphy, S. C., Zhao, M., Coleman, B., Sebree, R., Rodgers, K., Hooker, C. M., Franco, N., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0214 · Cited by 686
Lukas, J., Lukas, C., & Bartek, J. (2011) · Nature Cell Biology · doi:10.1038/ncb2344 · Cited by 645
Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining
Miller, K. M., Tjeertes, J. V., Coates, J., Legube, G., Polo, S. E., Britton, S., & Jackson, S. P. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1899 · Cited by 629
The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance
Bouwman, P., & Jonkers, J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3342 · Cited by 615
Murr, R., Loizou, J. I., Yang, Y.-G., Cuenin, C., Li, H., Wang, Z.-Q., & Herceg, Z. (2006) · Nature Cell Biology · doi:10.1038/ncb1343 · Cited by 613 · cited 2×
“, 2009), acetylating histones and relaxing chromatin, thus improving accessibility of DNA repair proteins to DSB sites (Murr et al., 2006).”
BackgroundTumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells
Nebbioso, A., Clarke, N., Voltz, E., Germain, E., Ambrosino, C., Bontempo, P., Alvarez, R., Schiavone, E. M., Ferrara, F., Bresciani, F., et al. (2005) · Nature Medicine · doi:10.1038/nm1161 · Cited by 610
Polo-like kinases: conservation and divergence in their functions and regulation
Archambault, V., & Glover, D. M. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2653 · Cited by 604
Hideshima, T., Bradner, J. E., Wong, J., Chauhan, D., Richardson, P., Schreiber, S. L., & Anderson, K. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503221102 · Cited by 593
The role of double-strand break repair — insights from human genetics
O'Driscoll, M., & Jeggo, P. A. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1746 · Cited by 583
Acetylation of the C Terminus of Ku70 by CBP and PCAF Controls Bax-Mediated Apoptosis
Cohen, H. Y., Lavu, S., Bitterman, K. J., Hekking, B., Imahiyerobo, T. A., Miller, C., Frye, R., Ploegh, H., Kessler, B. M., & Sinclair, D. A. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00094-2 · Cited by 578
MDM2–HDAC1-mediated deacetylation of p53 is required for its degradation
Ito, A., Kawaguchi, Y., Lai, C., Kovacs, J. J., Higashimoto, Y., Appella, E., & Yao, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf616 · Cited by 570
Peart, M. J., Smyth, G. K., van Laar, R. K., Bowtell, D. D., Richon, V. M., Marks, P. A., Holloway, A. J., & Johnstone, R. W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500369102 · Cited by 539
Liu, N., Lamerdin, J. E., Tebbs, R. S., Schild, D., Tucker, J. D., Shen, M. R., Brookman, K. W., Siciliano, M. J., Walter, C. A., Fan, W., et al. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80078-7 · Cited by 534
Mitsiades, C. S., Mitsiades, N. S., McMullan, C. J., Poulaki, V., Shringarpure, R., Hideshima, T., Akiyama, M., Chauhan, D., Munshi, N., Gu, X., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536759100 · Cited by 531
Insinga, A., Monestiroli, S., Ronzoni, S., Gelmetti, V., Marchesi, F., Viale, A., Altucci, L., Nervi, C., Minucci, S., & Pelicci, P. G. (2005) · Nature Medicine · doi:10.1038/nm1160 · Cited by 516
Human CtIP Mediates Cell Cycle Control of DNA End Resection and Double Strand Break Repair
Huertas, P., & Jackson, S. P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808906200 · Cited by 511
Butler, L. M., Zhou, X., Xu, W.-S., Scher, H. I., Rifkind, R. A., Marks, P. A., & Richon, V. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182372299 · Cited by 510
Ungerstedt, J. S., Sowa, Y., Xu, W.-S., Shao, Y., Dokmanovic, M., Perez, G., Ngo, L., Holmgren, A., Jiang, X., & Marks, P. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408732102 · Cited by 503
Ruefli, A. A., Ausserlechner, M. J., Bernhard, D., Sutton, V. R., Tainton, K. M., Kofler, R., Smyth, M. J., & Johnstone, R. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191208598 · Cited by 488
Carew, J. S., Nawrocki, S. T., Kahue, C. N., Zhang, H., Yang, C., Chung, L., Houghton, J. A., Huang, P., Giles, F. J., & Cleveland, J. L. (2007) · Blood · doi:10.1182/blood-2006-10-050260 · Cited by 488
The emerging role of nuclear architecture in DNA repair and genome maintenance
Misteli, T., & Soutoglou, E. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2651 · Cited by 470
Pérez-Galán, P., Roué, G., Villamor, N., Montserrat, E., Campo, E., & Colomer, D. (2006) · Blood · doi:10.1182/blood-2005-05-2091 · Cited by 467
(2003) · PubMed · Cited by 465
Ling, Y.-H., Liebes, L., Zou, Y., & Perez-Soler, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302559200 · Cited by 458
Histone H3 methylation links DNA damage detection to activation of the tumour suppressor Tip60
Sun, Y., Jiang, X., Xu, Y., Ayrapetov, M. K., Moreau, L. A., Whetstine, J. R., & Price, B. D. (2009) · Nature Cell Biology · doi:10.1038/ncb1982 · Cited by 454
Polo-like kinase-1 is a target of the DNA damage checkpoint
Smits, V. A. J., Klompmaker, R., Arnaud, L., Rijksen, G., Nigg, E. A., & Medema, R. H. (2000) · Nature Cell Biology · doi:10.1038/35023629 · Cited by 440
New Insights into Checkpoint Kinase 1 in the DNA Damage Response Signaling Network
Dai, Y., & Grant, S. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1029 · Cited by 439
Self-citationHDACs link the DNA damage response, processing of double-strand breaks and autophagy
Robert, T., Vanoli, F., Chiolo, I., Shubassi, G., Bernstein, K. A., Rothstein, R., Botrugno, O. A., Parazzoli, D., Oldani, A., Minucci, S., et al. (2011) · Nature · doi:10.1038/nature09803 · Cited by 412
Deroanne, C. F., Bonjean, K., Servotte, S., Devy, L., Colige, A., Clausse, N., Blacher, S., Verdin, E., Foidart, J.-M., Nusgens, B. V., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205108 · Cited by 400 · cited 2×
“…et al., 2010), vi. interference with proteasome function (Fotheringham et al., 2009; C. S. Mitsiades et al., 2004), vii. anti-angiogenic effects (Deroanne et al., 2002; Qian et al., 2004), viii. generation of the pro-apoptotic lipid second messenger ceramide (Maggio et al., 2004) and ix.…”
BackgroundPei, X.-Y., Dai, Y., & Grant, S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0561 · Cited by 382
Self-citationBhaskara, S., Chyla, B. J., Amann, J. M., Knutson, S. K., Cortez, D., Sun, Z.-W., & Hiebert, S. W. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.02.030 · Cited by 372
Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair
Lee, J.-H., Choy, M. L., Ngo, L., Foster, S. S., & Marks, P. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008522107 · Cited by 363
Modulation of p53, ErbB1, ErbB2, and Raf-1 Expression in Lung Cancer Cells by Depsipeptide FR901228
Yu, X. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.7.504 · Cited by 360
Hdac3 is essential for the maintenance of chromatin structure and genome stability
Bhaskara, S., Knutson, S. K., Jiang, G., Chandrasekharan, M. B., Wilson, A. J., Zheng, S., Yenamandra, A., Locke, K., Yuan, J.-L., Bonine-Summers, A. R., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.022 · Cited by 353
Function and regulation of protein neddylation
Rabut, G., & Peter, M. (2008) · EMBO reports · doi:10.1038/embor.2008.183 · Cited by 350
G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer
Bucher, N., & Britten, C. D. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604208 · Cited by 349
Munshi, A., Kurland, J. F., Nishikawa, T., Tanaka, T., Hobbs, M. L., Tucker, S. L., Ismail, S., Stevens, C., & Meyn, R. E. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2088 · Cited by 345
TNF-α-induced ROS production triggering apoptosis is directly linked to Romo1 and Bcl-XL
Kim, J. J., Lee, S. B., Park, J. K., & Yoo, Y. D. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2010.19 · Cited by 344
Catley, L., Weisberg, E., Kiziltepe, T., Tai, Y.-T., Hideshima, T., Neri, P., Tassone, P., Atadja, P., Chauhan, D., Munshi, N. C., et al. (2006) · Blood · doi:10.1182/blood-2006-04-016055 · Cited by 336
Involvement of Histone H1.2 in Apoptosis Induced by DNA Double-Strand Breaks
Konishi, A., Shimizu, S., Hirota, J., Takao, T., Fan, Y., Matsuoka, Y., Zhang, L., Yoneda, Y., Fujii, Y., Skoultchi, A. I., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00719-0 · Cited by 332
Milhollen, M. A., Traore, T., Adams-Duffy, J., Thomas, M. P., Berger, A. J., Dang, L., Dick, L. R., Garnsey, J. J., Koenig, E., Langston, S. P., et al. (2010) · Blood · doi:10.1182/blood-2010-03-272567 · Cited by 323
DNA Damage-Induced Acetylation of Lysine 3016 of ATM Activates ATM Kinase Activity
Sun, Y., Xu, Y., Roy, K., & Price, B. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01382-07 · Cited by 319
Sharma, G. G., So, S., Gupta, A., Kumar, R., Cayrou, C., Avvakumov, N., Bhadra, U., Pandita, R. K., Porteus, M. H., Chen, D. J., et al. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01476-09 · Cited by 313
Molecular sequelae of histone deacetylase inhibition in human malignant B cells
Mitsiades, N., Mitsiades, C. S., Richardson, P. G., McMullan, C., Poulaki, V., Fanourakis, G., Schlossman, R., Chauhan, D., Munshi, N. C., Hideshima, T., et al. (2003) · Blood · doi:10.1182/blood-2002-11-3514 · Cited by 294
Lin, J. J., Milhollen, M. A., Smith, P. G., Narayanan, U., & Dutta, A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2062 · Cited by 292
Richardson, P. G., Schlossman, R. L., Alsina, M., Weber, D. M., Coutre, S. E., Gasparetto, C., Mukhopadhyay, S., Ondovik, M. S., Khan, M., Paley, C. S., et al. (2013) · Blood · doi:10.1182/blood-2013-01-481325 · Cited by 290
The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma
Touzeau, C., Dousset, C., Le Gouill, S., Sampath, D., Leverson, J. D., Souers, A. J., Maïga, S., Béné, M. C., Moreau, P., Pellat-Deceunynck, C., et al. (2014) · Leukemia · doi:10.1038/leu.2013.216 · Cited by 289
Sallmyr, A., Fan, J., & Rassool, F. V. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.036 · Cited by 285
Vrana, J. A., Decker, R. H., Johnson, C. R., Wang, Z., Jarvis, W. D., Richon, V. M., Ehinger, M., Fisher, P. B., & Grant, S. (1999) · Oncogene · doi:10.1038/sj.onc.1203176 · Cited by 284
Self-citationFandy, T. E., Herman, J. G., Kerns, P., Jiemjit, A., Sugar, E. A., Choi, S.-H., Yang, A. S., Aucott, T., Dauses, T., Odchimar-Reissig, R., et al. (2009) · Blood · doi:10.1182/blood-2009-02-203547 · Cited by 282
Targeting BCL-2 with the BH3 Mimetic ABT-199 in Estrogen Receptor-Positive Breast Cancer
Vaillant, F., Merino, D., Lee, L., Breslin, K., Pal, B., Ritchie, M. E., Smyth, G. K., Christie, M., Phillipson, L. J., Burns, C. J., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.06.002 · Cited by 276
Nimmanapalli, R., Fuino, L., Bali, P., Gasparetto, M., Glozak, M. A., Tao, J., Moscinski, L. C., Smith, C. A., Wu, J., Jove, R., et al. (2003) · PubMed · Cited by 276
Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia
Swords, R. T., Kelly, K. R., Smith, P. G., Garnsey, J. J., Mahalingam, D., Medina, E., Oberheu, K., Padmanabhan, S., O'Dwyer, M., Nawrocki, S. T., et al. (2010) · Blood · doi:10.1182/blood-2009-11-254862 · Cited by 274
Hideshima, T., Richardson, P. G., & Anderson, K. C. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0433 · Cited by 265
Targeting the B-Cell Lymphoma/Leukemia 2 Family in Cancer
Davids, M. S., & Letai, A. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.0981 · Cited by 261
Yu, C., Rahmani, M., Conrad, D., Subler, M., Dent, P., & Grant, S. (2003) · Blood · doi:10.1182/blood-2003-03-0737 · Cited by 259
Self-citationFunction and Molecular Mechanism of Acetylation in Autophagy Regulation
Yi, C., Ma, M., Ran, L., Zheng, J., Tong, J., Zhu, J., Ma, C., Sun, Y., Zhang, S., Feng, W., et al. (2012) · Science · doi:10.1126/science.1216990 · Cited by 259
Qiu, L., Burgess, A., Fairlie, D. P., Leonard, H., Parsons, P. G., & Gabrielli, B. G. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.6.2069 · Cited by 249
Zhao, Y., Tan, J., Zhuang, L., Jiang, X., Liu, E. T., & Yu, Q. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505585102 · Cited by 246
Dai, Y., Rahmani, M., Dent, P., & Grant, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5429-5444.2005 · Cited by 245
Self-citation(2012) · doi:10.1158/0008-5472.can-12-0388 · Cited by 242
Nawrocki, S. T., Carew, J. S., Pino, M. S., Highshaw, R. A., Andtbacka, R. H. I., Dunner, K., Pal, A., Bornmann, W. G., Chiao, P. J., Huang, P., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2961 · Cited by 240
HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination
Adimoolam, S., Sirisawad, M., Chen, J., Thiemann, P., Ford, J. M., & Buggy, J. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707828104 · Cited by 236
Langerak, P., Mejia-Ramirez, E., Limbo, O., & Russell, P. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002271 · Cited by 231
Badros, A., Burger, A. M., Philip, S., Niesvizky, R., Kolla, S. S., Goloubeva, O., Harris, C., Zwiebel, J., Wright, J. J., Espinoza-Delgado, I., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2850 · Cited by 231
Self-citationQian, D. Z., Wang, X., Kachhap, S. K., Kato, Y., Wei, Y., Zhang, L., Atadja, P., & Pili, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0540 · Cited by 229
Nimmanapalli, R., Fuino, L., Stobaugh, C., Richon, V., & Bhalla, K. (2003) · Blood · doi:10.1182/blood-2002-08-2675 · Cited by 222
Munshi, A., Tanaka, T., Hobbs, M. L., Tucker, S. L., Richon, V. M., & Meyn, R. E. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0022 · Cited by 219
Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death
Gammoh, N., Lam, D., Puente, C., Ganley, I., Marks, P. A., & Jiang, X. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204429109 · Cited by 211
Camphausen, K., Burgan, W., Cerra, M., Oswald, K. A., Trepel, J. B., Lee, M.-J., & Tofilon, P. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2630 · Cited by 209
Namdar, M., Perez, G., Ngo, L., & Marks, P. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013754107 · Cited by 203
Guo, F., Sigua, C., Tao, J., Bali, P., George, P., Li, Y., Wittmann, S., Moscinski, L., Atadja, P., & Bhalla, K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2629 · Cited by 202
The C Terminus of Ku80 Activates the DNA-Dependent Protein Kinase Catalytic Subunit
Singleton, B. K., Torres-Arzayus, M. I., Rottinghaus, S. T., Taccioli, G. E., & Jeggo, P. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3267 · Cited by 201
Lindemann, R. K., Newbold, A., Whitecross, K. F., Cluse, L. A., Frew, A. J., Ellis, L., Williams, S., Wiegmans, A. P., Dear, A. E., Scott, C. L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702294104 · Cited by 199
Sampath, D., Liu, C., Vasan, K., Sulda, M., Puduvalli, V. K., Wierda, W. G., & Keating, M. J. (2012) · Blood · doi:10.1182/blood-2011-05-351510 · Cited by 197
Rahmani, M., Reese, E., Dai, Y., Bauer, C., Payne, S. G., Dent, P., Spiegel, S., & Grant, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2440 · Cited by 195
Self-citationLee, M.-H., & Yang, H.-Y. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000826 · Cited by 192
Vandenberg, C. J., & Cory, S. (2013) · Blood · doi:10.1182/blood-2013-01-475855 · Cited by 191
A Backup DNA Repair Pathway Moves to the Forefront
Nussenzweig, A., & Nussenzweig, M. C. (2007) · Cell · doi:10.1016/j.cell.2007.10.005 · Cited by 191
MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy
Nawrocki, S. T., Griffin, P., Kelly, K. R., & Carew, J. S. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.707192 · Cited by 186
Glick, R. D., Swendeman, S. L., Coffey, D. C., Rifkind, R. A., Marks, P. A., Richon, V. M., & Quaglia, M. P. L. (1999) · PubMed · Cited by 185
Marchion, D. C., Bicaku, E., Daud, A. I., Richon, V., Sullivan, D. M., & Munster, P. N. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20045 · Cited by 184
Saito, Y., Suzuki, H., Tsugawa, H., Nakagawa, I., Matsuzaki, J., Kanai, Y., & Hibi, T. (2009) · Oncogene · doi:10.1038/onc.2009.140 · Cited by 182
Xu, W., Ngo, L., Perez, G., Dokmanovic, M., & Marks, P. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607518103 · Cited by 179
Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response
Kao, G. D., McKenna, W. G., Guenther, M. G., Muschel, R. J., Lazar, M. A., & Yen, T. J. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200209065 · Cited by 179
Wang, Y., Fiskus, W., Chong, D. G., Buckley, K. M., Natarajan, K., Rao, R., Joshi, A., Balusu, R., Koul, S., Chen, J., et al. (2009) · Blood · doi:10.1182/blood-2009-05-222133 · Cited by 177
Polo-like kinase 1 reaches beyond mitosis—cytokinesis, DNA damage response, and development
Takaki, T., Trenz, K., Costanzo, V., & Petronczki, M. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.10.005 · Cited by 176
Mayo, M. W., Denlinger, C. E., Broad, R. M., Yeung, F., Reilly, E. T., Shi, Y., & Jones, D. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211695200 · Cited by 175
Ku70 acetylation mediates neuroblastoma cell death induced by histone deacetylase inhibitors
Subramanian, C., Opipari, A. W., Bian, X., Castle, V. P., & Kwok, R. P. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408351102 · Cited by 172
Deregulation of apoptosis in acute myeloid leukemia
Testa, U., & Riccioni, R. (2007) · Haematologica · doi:10.3324/haematol.10279 · Cited by 171
Aron, J. L., Parthun, M. R., Marcucci, G., Kitada, S., Mone, A. P., Davis, M. E., Shen, T., Murphy, T., Wickham, J., Kanakry, C., et al. (2003) · Blood · doi:10.1182/blood-2002-12-3794 · Cited by 171
Insinga, A., Monestiroli, S., Ronzoni, S., Gelmetti, V, Marchesi, F., Viale, A., Altucci, L., Nervi, C., Minucci, S., & Pelicci, P. G. (2005) · Nature Medicine · doi:10.1038/nm0205-233a · Cited by 168
Quintás‐Cardama, A., Santos, F. P. D. S., & Garcia‐Manero, G. (2010) · Leukemia · doi:10.1038/leu.2010.276 · Cited by 166
Targeting Checkpoint Kinase 1 in Cancer Therapeutics
Tse, A. N., Carvajal, R. D., & Schwartz, G. K. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2793 · Cited by 166
Labi, V, Grespi, F., Baumgartner, F., & Villunger, A. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.37 · Cited by 165
Schrump, D. S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2787 · Cited by 165
Yu, C., Rahmani, M., Dent, P., & Grant, S. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.02.001 · Cited by 164
Self-citationRenner, A. G., Santos, C. D., Récher, C., Bailly, C., Créancier, L., Kruczynski, A., Payrastre, B., & Manenti, S. (2009) · Blood · doi:10.1182/blood-2008-12-195867 · Cited by 163
Garcia-Manero, G., Tambaro, F. P., Bekele, N. B., Yang, H., Ravandi, F., Jabbour, E., Borthakur, G., Kadia, T. M., Konopleva, M. Y., Faderl, S., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.3265 · Cited by 163
Milhollen, M. A., Narayanan, U., Soucy, T. A., Veiby, P. O., Smith, P. G., & Amidon, B. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2122 · Cited by 159
Conti, C., Leo, E., Eichler, G. S., Sordet, O., Martin, M. M., Fan, A. M., Aladjem, M. I., & Pommier, Y. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3028 · Cited by 159
Inoue, S., MacFarlane, M., Harper, N. W., Wheat, L. M. C., Dyer, M. J. S., & Cohen, G. M. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401535 · Cited by 158
Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect
Dickinson, M. J., Johnstone, R. W., & Prince, H. M. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9596-y · Cited by 157
Kachhap, S. K., Rosmus, N., Collis, S. J., Kortenhorst, M. S. Q., Wissing, M. D., Hedayati, M. A., Shabbeer, S., Mendonca, J., Deangelis, J., Marchionni, L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011208 · Cited by 154
Robert, C., & Rassool, F. V. (2012) · Advances in cancer research · doi:10.1016/b978-0-12-394387-3.00003-3 · Cited by 153
Tumor cell‐specific cytotoxicity by targeting cell cycle checkpoints
Warrener, R., Beamish, H., Burgess, A., Waterhouse, N. J., Giles, N., Fairlie, D. P., & Gabrielli, B. G. (2003) · The FASEB Journal · doi:10.1096/fj.02-1003fje · Cited by 149
Rascle, A., Johnston, J. A., & Amati, B. B. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.12.4162-4173.2003 · Cited by 145
Fiskus, W. C., Pranpat, M., Bali, P., Balasis, M. E., Kumaraswamy, S., Boyapalle, S., Rocha, K., Wu, J., Giles, F. J., Manley, P. W., et al. (2006) · Blood · doi:10.1182/blood-2005-11-4639 · Cited by 145
Chen, S., Dai, Y., Pei, X., & Grant, S. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01481-08 · Cited by 142
Self-citationVorinostat Induces Reactive Oxygen Species and DNA Damage in Acute Myeloid Leukemia Cells
Petruccelli, L. A., Dupéré-Richer, D., Pettersson, F., Retrouvey, H., Skoulikas, S., & Miller, W. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020987 · Cited by 141
Almenara, J., Rosato, R., & Grant, S. (2002) · Leukemia · doi:10.1038/sj.leu.2402535 · Cited by 141
Self-citationHistone deacetylase inhibitors: insights into mechanisms of lethality
Rosato, R. R., & Grant, S. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.4.809 · Cited by 139
Self-citationFotheringham, S., Epping, M. T., Stimson, L., Khan, O., Wood, V., Pezzella, F., Bernards, R., & La Thangue, N. B. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.001 · Cited by 138
Maggio, S. C., Rosato, R. R., Kramer, L. B., Dai, Y., Rahmani, M., Paik, D. S., Czarnik, A. C., Payne, S. G., Spiegel, S., & Grant, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2631 · Cited by 134
Self-citationYu, C., Rahmani, M., Almenara, J. A., Subler, M. A., Krystal, G. W., Conrad, D. H., Varticovski, L., Dent, P., & Grant, S. (2003) · PubMed · Cited by 132
Self-citationThompson, R. H., & Eastman, A. R. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12139 · Cited by 128
Bali, P., George, P., Cohen, P. S., Tao, J., Guo, F., Sigua, C. A., Vishvanath, A., Scuto, A., Annavarapu, S., Fiskus, W. C., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0210 · Cited by 128
Bachmann, P. S., Piazza, R., Janes, M. E., Wong, N. C., Davies, C. H., Mogavero, A., Bhadri, V. A., Szymanska, B., Geninson, G., Magistroni, V., et al. (2010) · Blood · doi:10.1182/blood-2010-05-284968 · Cited by 126
Apoptosis induced by histone deacetylase inhibitors in leukemic cells is mediated by Bim and Noxa
Inoue, S., Riley, J., Gant, T. W., Dyer, M. J. S., & Cohen, G. M. (2007) · Leukemia · doi:10.1038/sj.leu.2404760 · Cited by 125
Sodium butyrate induces new gene expression in Friend erythroleukemic cells.
Reeves, R., & Cserjesi, P. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50727-4 · Cited by 124
Rosato, R. R., Almenara, J. A., Maggio, S. C., Coe, S., Atadja, P. W., Dent, P., & Grant, S. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0385 · Cited by 124
Self-citationKarp, J. E., Thomas, B. M., Greer, J. M., Sorge, C. L., Gore, S. D., Pratz, K. W., Smith, B. D., Flatten, K. S., Peterson, K., Schneider, P. A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2442 · Cited by 123
Cerchietti, L. C. A., Hatzi, K., Caldas-Lopes, E., Yang, S. N., Figueroa, M. E., Morin, R. D., Hirst, M., Mendez, L., Shaknovich, R., Cole, P. A., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42869 · Cited by 121
Gaymes, T. J., Padua, R. A., Pla, M., Orr, S. J., Omidvar, N., Chomienne, C., Mufti, G. J., & Rassool, F. V. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0111 · Cited by 120
Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma
Richter, J. Á., Robles, E. F., Fresquet, V., Beltrán, E., Rullan, A., Agirre, X., Calasanz, M. J., Panizo, C., Richter, J. Á., Hernández‐Rivas, J. M., et al. (2010) · Blood · doi:10.1182/blood-2010-02-268003 · Cited by 119
Nawrocki, S. T., Kelly, K. R., Smith, P. G., Espitia, C. M., Possemato, A. P., Beausoleil, S. A., Milhollen, M. A., Blakemore, S. J., Thomas, M., Berger, A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3212 · Cited by 117
Terui, T., Murakami, K., Takimoto, R., Takahashi, M., Takada, K., Murakami, T., Minami, S., Matsunaga, T., Takayama, T., Kato, J., et al. (2003) · PubMed · Cited by 116
Sensing of Ionizing Radiation-induced DNA Damage by ATM through Interaction with Histone Deacetylase
Kim, G. D., Choi, Y. H., Dimtchev, A., Jeong, S. J., Dritschilo, A., & Jung, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31127 · Cited by 111
Ishii, S., KURASAWA, Y., Wong, J., & Yu‐Lee, L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710140105 · Cited by 111
Novotny‐Diermayr, V., Hart, S., Goh, K. C., Cheong, A., Ong, L. C., Hentze, H., Pasha, M. K., Jayaraman, R., Ethirajulu, K., & Wood, J. M. (2012) · Blood Cancer Journal · doi:10.1038/bcj.2012.14 · Cited by 109
Calsou, P., Frit, P., Humbert, O., Muller, C., Chen, D. J., & Salles, B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7848 · Cited by 108
Stathis, A., Hotte, S. J., Chen, E. X., Hirte, H. W., Oza, A. M., Moretto, P., Webster, S., Laughlin, A., Stayner, L.-A., McGill, S., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1893 · Cited by 107
Bhalla, S., Balasubramanian, S., David, K. A., Sirisawad, M., Buggy, J. J., Mauro, L. A., Prachand, S., Miller, R. A., Gordon, L. I., & Evens, A. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2365 · Cited by 107
Kerr, E. M., Holohan, C., McLaughlin, K. M., Majkut, J., Dolan, S., Redmond, K. M., Riley, J. S., McLaughlin, K. M., Stasik, I., Crudden, M. T. C. M., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.8 · Cited by 106
Vogler, M., Dinsdale, D. D., Dyer, M. J. S., & Cohen, G. M. (2013) · British Journal of Haematology · doi:10.1111/bjh.12457 · Cited by 105
Histone Deacetylases 9 and 10 Are Required for Homologous Recombination
Kotian, S., Liyanarachchi, S., Zelent, A., & Parvin, J. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.194233 · Cited by 104
Hu, Y., Lu, W., Chen, G., Zhang, H., Jia, Y., Wei, Y., Yang, H., Zhang, W., Fiskus, W. C., Bhalla, K. N., et al. (2010) · Blood · doi:10.1182/blood-2009-11-256354 · Cited by 104
Fiskus, W. C., Pranpat, M., Balasis, M. E., Bali, P., Estrella, V. C., Kumaraswamy, S., Rao, R., Rocha, K., Herger, B. E., Lee, F. Y., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0980 · Cited by 102
Fan, J., Li, L., Small, D., & Rassool, F. V. (2010) · Blood · doi:10.1182/blood-2010-03-272591 · Cited by 97
Shao, W., Growney, J. D., Feng, Y., O'Connor, G., Pu, M., Zhu, W., Yao, Y.-M. M., Kwon, P. O., Fawell, S. E., & Atadja, P. W. (2010) · International Journal of Cancer · doi:10.1002/ijc.25218 · Cited by 97
XIAP Regulates DNA Damage-induced Apoptosis Downstream of Caspase-9 Cleavage
Datta, R., Oki, E., Endo, K., Biedermann, V., Ren, J., & Kufe, D. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910231199 · Cited by 96
Histone deacetylase inhibitors induce mitotic slippage
Stevens, F., Beamish, H., Warrener, R., & Gabrielli, B. G. (2007) · Oncogene · doi:10.1038/sj.onc.1210779 · Cited by 95
Rao, R., Nalluri, S., Kolhe, R. B., Yang, Y., Fiskus, W. C., Chen, J., Ha, K., Buckley, K. M., Balusu, R., Coothankandaswamy, V., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0988 · Cited by 94
Mitochondrial targeting of tBid/Bax: a role for the TOM complex?
Ott, M., Norberg, E., Zhivotovsky, B., & Orrenius, S. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.61 · Cited by 92
Basile, V., Mantovani, R., & Imbriano, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507712200 · Cited by 91
Xargay‐Torrent, S., López‐Guerra, M., Saborit-Villarroya, I., Rosich, L., Campo, E., Roué, G., & Colomer, D. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3412 · Cited by 91
Interactions between Bortezomib and Romidepsin and Belinostat in Chronic Lymphocytic Leukemia Cells
Dai, Y., Chen, S., Kramer, L. B., Funk, V. L., Dent, P., & Grant, S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1934 · Cited by 90
Self-citationLi, H., & Wu, X. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.130 · Cited by 89
Chakraborty, A. R., Robey, R. W., Luchenko, V. L., Zhan, Z., Piekarz, R., Gillet, J., Kossenkov, A. V., Wilkerson, J., Showe, L. C., Gottesman, M. M., et al. (2013) · Blood · doi:10.1182/blood-2012-08-449140 · Cited by 89
Bangert, A., Cristofanon, S., Eckhardt, I., Abhari, B. A., Kolodziej, S., Häcker, S., Vellanki, S. H., Lausen, J., Debatin, K., & Fulda, S. (2012) · Oncogene · doi:10.1038/onc.2011.614 · Cited by 87
Gleixner, K. V., Ferenc, V., Peter, B., Gruze, A., Meyer, R. A., Hadzijusufovic, E., Cerny‐Reiterer, S., Mayerhofer, M., Pickl, W. F., Sillaber, C., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2181 · Cited by 87
Gillenwater, A. M., Zhong, M., & Lotan, R. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0344 · Cited by 87
Nguyen, T., Dai, Y., Attkisson, E., Kramer, L. B., Jordan, N., Nguyen, N., Kolluri, N., Müschen, M., & Grant, S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0234 · Cited by 84
Self-citationNishioka, C., Ikezoe, T., Yang, J., Takeuchi, S., Koeffler, H. P., & Yokoyama, A. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.02.018 · Cited by 82
Antileukemia activity of the combination of an anthracycline with a histone deacetylase inhibitor
Sánchez‐González, B., Yang, H., Bueso-Ramos, C., Hoshino, K., Quintás‐Cardama, A., Richon, V. M., & Garcia‐Manero, G. (2006) · Blood · doi:10.1182/blood-2005-09-008086 · Cited by 82
Ha, K., Fiskus, W. C., Rao, R., Balusu, R., Venkannagari, S., Nalabothula, N. R., & Bhalla, K. N. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0094 · Cited by 82
Gillespie, S., Borrow, J. M., Zhang, X. D., & Hersey, P. (2006) · APOPTOSIS · doi:10.1007/s10495-006-0283-6 · Cited by 81
Tanaka, A., Tanizawa, H., Sriswasdi, S., Iwasaki, O., Chatterjee, A. G., Speicher, D. W., Levin, H. L., Noguchi, E., & Noma, K.-I. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.011 · Cited by 79
Kim, E. H., Kim, H. S., Kim, S. U., Noh, E. J., Lee, J., & Choi, K. S. (2005) · Oncogene · doi:10.1038/sj.onc.1208851 · Cited by 78
Jazaeri, A. A., Shibata, E., Park, J.-H., Bryant, J. L., Conaway, M. R., Modesitt, S. C., Smith, P. G., Milhollen, M. A., Berger, A., & Dutta, A. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1028 · Cited by 78
Targeting protein neddylation: a novel therapeutic strategy for the treatment of cancer
Wang, M., Medeiros, B. C., Erba, H. P., DeAngelo, D. J., Giles, F. J., & Swords, R. T. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.550877 · Cited by 77
Dai, Y., Guzmán, M. L., Chen, S., Wang, L., Yeung, S., Pei, X., Dent, P., Jordan, C. T., & Grant, S. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08319.x · Cited by 76
Self-citationBrazelle, W., Kreahling, J. M., Gemmer, J. Y., Ma, Y., Cress, W. D., Haura, E. B., & Altiok, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014335 · Cited by 75
Tanaka, R., Squires, M. S., Kimura, S. H., Yokota, A., Nagao, R., Yamauchi, T., Takeuchi, M., Yao, H., Reule, M., Smyth, T., et al. (2010) · Blood · doi:10.1182/blood-2009-03-211466 · Cited by 73
CeBRC-2 Stimulates D-loop Formation by RAD-51 and Promotes DNA Single-strand Annealing
Petalcorin, M. I. R., Sandall, J. K., Wigley, D. B., & Boulton, S. J. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.06.020 · Cited by 71
Cited by
SCFA: mechanisms and functional importance in the gut
Martin-Gallausiaux, C., Marinelli, L., Blottière, H. M., Larraufie, P., & Lapaque, N. (2021) · Proceedings of the Nutrition Society · doi:10.1017/s0029665120006916 · Cited by 1,480
Epigenetic Determinants of Cancer
Baylin, S. B., & Jones, P. A. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019505 · Cited by 1,226
Histone Deacetylase Inhibitors as Anticancer Drugs
Eckschlager, T., Plch, J., Stiborova, M., & Hrabeta, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071414 · Cited by 1,206
Nogal, A., Valdes, A. M., & Menni, C. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1897212 · Cited by 917
Targeting DNA Repair in Cancer: Beyond PARP Inhibitors
Brown, J. S., O'Carrigan, B., Jackson, S. P., & Yap, T. A. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0860 · Cited by 618
Metadata
- Authors
- Bose, P., Dai, Y., & Grant, S.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 143
- Issue
- 3
- Pages
- 323-336
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2064609355
- Cited by
- 280
- References
- 249
- FWCI
- 12.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.